1. Adams EW, Ratner DM, Bokesch HR, McMahon JB, O'Keefe BR, Seeberger PH. 2004. Oligosaccharide and glycoprotein microarrays as tools in HIV glycobiology; glycan-dependent gp120/protein interactions. Chem Biol, 11: 875–881.
2. Alama SM, Dennisona SM, Aussedatd B, Vohrad Y, Parkd PK, Fernández-Tejadad A, Stewarta S, Jaegera FH, Anastia K, Blinna JH, Keplere TB, Bonsignori M, Liao H-X, Sodroski JG, Danishefsky SJ, Haynesa BF. 2013. Recognition of synthetic glycopeptides by HIV-1 broadly neutralizing antibodies and their unmutated ancestors. Proc Natl Acad Sci U S A, 110: 18214–18219.
3. Anish C, Schumann B, Pereira CL, Seeberger PH. 2014. Chemical biology approaches to designing defined carbohydrate vaccines. Chem Biol, 21: 38–50.
4. Astronomo RD, Burton DR. 2010. Carbohydrate vaccines: developing sweet solutions to sticky situations? Nat Rev Drug Discov, 9: 308–324.
5. Astronomo RD, Kaltgrad E, Udit AK, Wang SK, Doores KJ, Huang CY, Pantophlet R, Paulson JC, Wong CH, Finn MG, Burton DR. 2010. Defining criteria for oligomannose immunogens for HIV using icosahedral virus capsid scaffolds. Chem Biol, 17: 357–370.